Navellier & Associates Inc Bio Techne Corp Transaction History

Navellier & Associates Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$282.54 - $391.85 $12,714 - $17,633	-45 Reduced 1.43%	3,103 $881,000
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $1.02 Million - $1.42 Million	3,148 New	3,148 $1.09 Million
Q1 2022 Apr 29, 2022	SELL	$353.85 - $487.79 $5.18 Million - $7.15 Million	-14,648 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $2.71 Million - $3.12 Million	-5,944 Reduced 28.87%	14,648 $7.58 Million
Q3 2021 Oct 28, 2021	BUY	$444.87 - $538.88 $1,779 - $2,155	4 Added 0.02%	20,592 $9.98 Million
Q2 2021 Aug 09, 2021	BUY	$387.35 - $450.26 $12,395 - $14,408	32 Added 0.16%	20,588 $9.27 Million
Q1 2021 May 12, 2021	BUY	$314.62 - $411.0 $6.47 Million - $8.45 Million	20,556 New	20,556 $7.85 Million
Q3 2020 Nov 09, 2020	SELL	$232.22 - $282.96 $404,295 - $492,633	-1,741 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$185.43 - $279.56 $36,529 - $55,073	-197 Reduced 10.17%	1,741 $460,000
Q1 2020 May 13, 2020	SELL	$161.17 - $221.51 $24,175 - $33,226	-150 Reduced 7.18%	1,938 $367,000
Q4 2019 Feb 12, 2020	BUY	$189.68 - $222.09 $97,495 - $114,154	514 Added 32.66%	2,088 $458,000
Q3 2019 Oct 16, 2019	BUY	$183.56 - $216.72 $288,923 - $341,117	1,574 New	1,574 $308,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.